Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine…
Researchers found a new vulnerability in cancer cells that resist EGFR drugs, suggesting a combination therapy approach that could delay treatment resistance in lung cancer.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Spatially interpretable artificial intelligence framework to tailored…
An AI model can read tumor structure to predict which HER2-positive breast cancer patients will respond best to standard combination therapy, filling a critical gap in treatment planning.
Standard additionShort-Term Versus Long-Term Efficacy of Endoscopic Sleeve…
A comprehensive analysis of nearly 9,000 patients confirms that minimally invasive gastric procedures produce meaningful weight loss, offering an alternative for people who cannot tolerate or access other treatments.
Promising but preliminaryEnd-to-End PET/CT Interpretation and Quantification with an…
An AI system successfully performed complete PET scan interpretation and reporting autonomously, potentially freeing radiologists to focus on complex cases.
Underserved or high-risk populationsTrends and Disparities in CAR-T Therapy Utilization, Inpatient…
Documentation of expanding CAR-T cell therapy access alongside persistent racial and geographic disparities highlights where health systems need to improve equity in this life-saving treatment.